# PGE1 Improves Coronary Microcirculation Dysfunction in Patients With CAD and Diabetes

> **NCT03159559** · PHASE4 · UNKNOWN · sponsor: **Tongji Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Coronary Microvascular Perfusion in Patients With Ischemic Heart Disease

## Interventions

- **DRUG:** Lipo-PGE1

## Key facts

- **NCT ID:** NCT03159559
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2017-12
- **Final completion:** 2018-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2017-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03159559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03159559, "PGE1 Improves Coronary Microcirculation Dysfunction in Patients With CAD and Diabetes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03159559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*